Latest receivables for ESALF: $240B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Eisai , Ltd. (ESALF) currently reports a receivables of $240B as of September 2026. That compares with $220B in the prior-year period — up 6.0% year over year. Use the charts on this page to explore Eisai , Ltd.'s receivables history and peer comparisons.
Eisai , Ltd.'s receivables increased from $220B to $240B — a 6.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Eisai , Ltd. reported $240B in receivables as of September 2026. That compares with $220B in the prior-year period — up 6.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $240B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eisai , Ltd., and consider following ESALF for alerts when major investors trade the stock.
Eisai , Ltd. is classified in the Healthcare sector. On receivables, it currently shows $240B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ESALF with unrelated industries.